Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Effect of Clostridium perfringens β-Toxin on Platelets.

Thiel A, Mogel H, Bruggisser J, Baumann A, Wyder M, Stoffel MH, Summerfield A, Posthaus H.

Toxins (Basel). 2017 Oct 24;9(10). pii: E336. doi: 10.3390/toxins9100336.

2.

Native or Proteolytically Activated NanI Sialidase Enhances the Binding and Cytotoxic Activity of Clostridium perfringens Enterotoxin and Beta Toxin.

Theoret JR, Li J, Navarro MA, Garcia JP, Uzal FA, McClane BA.

Infect Immun. 2017 Dec 19;86(1). pii: e00730-17. doi: 10.1128/IAI.00730-17. Print 2018 Jan.

PMID:
29038129
3.

NanR Regulates nanI Sialidase Expression by Clostridium perfringens F4969, a Human Enteropathogenic Strain.

Li J, Evans DR, Freedman JC, McClane BA.

Infect Immun. 2017 Aug 18;85(9). pii: e00241-17. doi: 10.1128/IAI.00241-17. Print 2017 Sep.

PMID:
28652312
4.

Clostridium perfringens Sialidases: Potential Contributors to Intestinal Pathogenesis and Therapeutic Targets.

Li J, Uzal FA, McClane BA.

Toxins (Basel). 2016 Nov 19;8(11). pii: E341. Review.

5.

Regulation of Toxin Production in Clostridium perfringens.

Ohtani K, Shimizu T.

Toxins (Basel). 2016 Jul 5;8(7). pii: E207. doi: 10.3390/toxins8070207. Review.

6.

The C-terminal domain of Clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis.

Goossens E, Verherstraeten S, Valgaeren BR, Pardon B, Timbermont L, Schauvliege S, Rodrigo-Mocholí D, Haesebrouck F, Ducatelle R, Deprez PR, Van Immerseel F.

Vet Res. 2016 Apr 27;47(1):52. doi: 10.1186/s13567-016-0336-y.

7.

The interaction of Clostridium perfringens enterotoxin with receptor claudins.

Shrestha A, Uzal FA, McClane BA.

Anaerobe. 2016 Oct;41:18-26. doi: 10.1016/j.anaerobe.2016.04.011. Epub 2016 Apr 16. Review.

8.

Use of aminoglycoside 3' adenyltransferase as a selection marker for Chlamydia trachomatis intron-mutagenesis and in vivo intron stability.

Lowden NM, Yeruva L, Johnson CM, Bowlin AK, Fisher DJ.

BMC Res Notes. 2015 Oct 15;8:570. doi: 10.1186/s13104-015-1542-9.

9.

NanI Sialidase, CcpA, and CodY Work Together To Regulate Epsilon Toxin Production by Clostridium perfringens Type D Strain CN3718.

Li J, Freedman JC, McClane BA.

J Bacteriol. 2015 Oct;197(20):3339-53. doi: 10.1128/JB.00349-15. Epub 2015 Aug 10.

10.

Perfringolysin O: The Underrated Clostridium perfringens Toxin?

Verherstraeten S, Goossens E, Valgaeren B, Pardon B, Timbermont L, Haesebrouck F, Ducatelle R, Deprez P, Wade KR, Tweten R, Van Immerseel F.

Toxins (Basel). 2015 May 14;7(5):1702-21. doi: 10.3390/toxins7051702. Review.

11.

Binding studies on isolated porcine small intestinal mucosa and in vitro toxicity studies reveal lack of effect of C. perfringens beta-toxin on the porcine intestinal epithelium.

Roos S, Wyder M, Candi A, Regenscheit N, Nathues C, van Immerseel F, Posthaus H.

Toxins (Basel). 2015 Apr 9;7(4):1235-52. doi: 10.3390/toxins7041235.

12.

The CpAL quorum sensing system regulates production of hemolysins CPA and PFO to build Clostridium perfringens biofilms.

Vidal JE, Shak JR, Canizalez-Roman A.

Infect Immun. 2015 Jun;83(6):2430-42. doi: 10.1128/IAI.00240-15. Epub 2015 Mar 30.

13.

Characterization of Clostridium perfringens TpeL toxin gene carriage, production, cytotoxic contributions, and trypsin sensitivity.

Chen J, McClane BA.

Infect Immun. 2015 Jun;83(6):2369-81. doi: 10.1128/IAI.03136-14. Epub 2015 Mar 30.

14.

Structure-function analysis of peptide signaling in the Clostridium perfringens Agr-like quorum sensing system.

Ma M, Li J, McClane BA.

J Bacteriol. 2015 May;197(10):1807-18. doi: 10.1128/JB.02614-14. Epub 2015 Mar 16.

15.

Animal models to study the pathogenesis of human and animal Clostridium perfringens infections.

Uzal FA, McClane BA, Cheung JK, Theoret J, Garcia JP, Moore RJ, Rood JI.

Vet Microbiol. 2015 Aug 31;179(1-2):23-33. doi: 10.1016/j.vetmic.2015.02.013. Epub 2015 Feb 25. Review.

16.

Recent insights into Clostridium perfringens beta-toxin.

Nagahama M, Ochi S, Oda M, Miyamoto K, Takehara M, Kobayashi K.

Toxins (Basel). 2015 Feb 3;7(2):396-406. doi: 10.3390/toxins7020396. Review.

17.

Identification and characterization of Clostridium perfringens beta toxin variants with differing trypsin sensitivity and in vitro cytotoxicity activity.

Theoret JR, Uzal FA, McClane BA.

Infect Immun. 2015 Apr;83(4):1477-86. doi: 10.1128/IAI.02864-14. Epub 2015 Feb 2.

18.

Clostridium perfringens type A-E toxin plasmids.

Freedman JC, Theoret JR, Wisniewski JA, Uzal FA, Rood JI, McClane BA.

Res Microbiol. 2015 May;166(4):264-79. doi: 10.1016/j.resmic.2014.09.004. Epub 2014 Oct 2. Review.

19.

Synergistic effects of Clostridium perfringens enterotoxin and beta toxin in rabbit small intestinal loops.

Ma M, Gurjar A, Theoret JR, Garcia JP, Beingesser J, Freedman JC, Fisher DJ, McClane BA, Uzal FA.

Infect Immun. 2014 Jul;82(7):2958-70. doi: 10.1128/IAI.01848-14. Epub 2014 Apr 28.

20.

Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease.

Uzal FA, Freedman JC, Shrestha A, Theoret JR, Garcia J, Awad MM, Adams V, Moore RJ, Rood JI, McClane BA.

Future Microbiol. 2014;9(3):361-77. doi: 10.2217/fmb.13.168. Review.

Supplemental Content

Support Center